Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?Maximilian Huttasch, S. Kahl, Michael Roden|Metabolism|2024Cited by 137
Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction–associated steatohepatitisIkki Sakuma, Gerald I. Shulman, Rafael Calais Gaspar et al.|Proceedings of the National Academy of Sciences|2025Cited by 33
Intramyocellular Triglyceride Content During the Early Course of Type 1 and Type 2 DiabetesMartin Schön, E. Lammert, Wolfgang Rathmann et al.|Diabetes|2023Cited by 11
Association of thyroid function with non‐alcoholic fatty liver disease in recent‐onset diabetesNina Saatmann, Martin Schön, Oana‐Patricia Zaharia et al.|Liver International|2023Cited by 8
PNPLA3 gene variation modulates diet-induced improvement in liver lipid content in type 2 diabetesKalliopi Pafili, Michael Roden, Oana‐Patricia Zaharia et al.|Clinical Nutrition|2025Cited by 4